Breaking News Instant updates and real-time market news.

LPCN

Lipocine

$4.60

-0.82 (-15.13%)

13:06
10/13/16
10/13
13:06
10/13/16
13:06

Lipocine drops after Clarus provides view on patent case against company

Shares of Lipocine (LPCN), an oral drug delivery technology company, are dropping after Clarus Therapeutics commented on its patent infringement lawsuit against Lipocine. WHAT'S NEW: On October 7, Lipocine announced that U.S. District Court in Delaware granted its motion to dismiss a lawsuit filed by Clarus Therapeutics. Clarus claimed that LPCN 1021 infringed Clarus' patent. LPCN 1021 is Lipocine's oral testosterone product candidate for testosterone replacement therapy, or TRT, in adult males for conditions associated with a deficiency or absence of endogenous testosterone, also known as hypogonadism. "We are pleased that the court has dismissed this lawsuit. Going forward, we will continue to aggressively defend our intellectual property," said Dr. Mahesh Patel, President and CEO of Lipocine. WHAT'S NOTABLE: Before the opening of trading this morning, Clarus Therapeutics commented on the prior ruling, noting that the court found that there was not an immediate reason to hear the case given Lipocine's failure to receive FDA market approval for LPCN 1021. Importantly, the decision was made without ruling on the validity of Clarus's U.S. Patent 8,828,428 and other merits of the case. Clarus CEO Dr. Robert Dudley said, "We remain strong in our belief that LPCN 1021 infringes Clarus's '428 patent and it is particularly noteworthy that the court did not rule on this central fact. If LPCN 1021 were to be approved by the FDA, our plan would be to vigorously pursue all avenues to keep Lipocine's LPCN 1021 from entering the market and protect the intellectual property, accompanying financial investment and years of work we have invested in JATENZO -- our oral TRT product." ANALYST VIEWS: Earlier this week, Canaccord analyst John Newman raised his price target on Lipocine to $15 from $6 as he said at the time that believes its oral testosterone product has better safety and convenience versus currently marketed gels and injectables. The analyst sees rapid market share gains and a 20% market share by 2024. Newman reiterated his Buy rating on Lipocine shares. Additionally, on October 7 H.C. Wainwright analyst Corey Davis started Lipocine with a Buy rating and $25 price target. PRICE ACTION: Shares of Lipocine are lower by 35c, or 7.6%, to $4.25 in afternoon trading.

LPCN Lipocine
$4.60

-0.82 (-15.13%)

06/30/16
ROTH
06/30/16
NO CHANGE
Target $30
ROTH
Buy
Lipocine price target lowered to $30 from $40 at Roth Capital
Roth Capital analyst Michael Higgins lowered his price target for Lipocine to $30 from $40 after the FDA issued a Complete Response Letter on Lipocine's oral testosterone product, LPCN 1021, citing "deficiencies related to the dosing algorithm." Roth Capital has a Buy rating on the shares.
10/07/16
HCWC
10/07/16
INITIATION
Target $25
HCWC
Buy
Lipocine initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Corey Davis started Lipocine with a Buy rating and $25 price target.
10/11/16
ADAM
10/11/16
NO CHANGE
Target $15
ADAM
Buy
Lipocine price target raised to $15 from $6 at Canaccord
Canaccord analyst John Newman raised his price target on Lipocine to $15 from $6 as he believes its oral testosterone product has better safety and convenience versus currently marketed gels and injectables. The analyst sees rapid market share gains and a 20% market share by 2024. Newman reiterated his Buy rating on Lipocine shares.

TODAY'S FREE FLY STORIES

SSD

Simpson Manufacturing

$44.24

-0.62 (-1.38%)

08:59
02/23/17
02/23
08:59
02/23/17
08:59
Hot Stocks
Simpson Manufacturing to adopt proxy access bylaws amendment »

Simpson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSS

Kohl's

08:57
02/23/17
02/23
08:57
02/23/17
08:57
Hot Stocks
Kohl's says has 'nothing specific in mind' on M&A »

Says company in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 19

    Mar

AGN

Allergan

$246.32

-0.84 (-0.34%)

08:56
02/23/17
02/23
08:56
02/23/17
08:56
Periodicals
Allergan CEO proposes Trump lead drug price negotiations, Bloomberg reports »

Allergan CEO Brent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 04

    May

BAC

Bank of America

$24.79

0.01 (0.04%)

, TSLA

Tesla

$273.51

-3.88 (-1.40%)

08:56
02/23/17
02/23
08:56
02/23/17
08:56
Options
Notable open interest changes for February 23rd »

Wednesday's total…

BAC

Bank of America

$24.79

0.01 (0.04%)

TSLA

Tesla

$273.51

-3.88 (-1.40%)

JCP

J.C. Penney

$7.05

-0.01 (-0.14%)

FB

Facebook

$136.12

2.4 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 24

    Feb

  • 28

    Feb

  • 28

    Feb

  • 06

    Mar

  • 19

    Mar

  • 28

    Mar

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:55
02/23/17
02/23
08:55
02/23/17
08:55
Hot Stocks
Breaking Hot Stocks news story on Tennant 

Tennant trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

SFTBF

SoftBank

$76.90

-0.3575 (-0.46%)

, VOD

Vodafone

08:55
02/23/17
02/23
08:55
02/23/17
08:55
Periodicals
SoftBank in talks to buy stake in Vodafone Indian unit, The Economic Times says »

Softbank (SFTBF) could…

SFTBF

SoftBank

$76.90

-0.3575 (-0.46%)

VOD

Vodafone

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:55
02/23/17
02/23
08:55
02/23/17
08:55
General news
The 6k U.S. initial claims rise to 244k »

The 6k U.S. initial…

THG

Hanover Insurance

$91.08

0.43 (0.47%)

08:55
02/23/17
02/23
08:55
02/23/17
08:55
Conference/Events
Hanover Insurance to host investor day »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 05

    Mar

HNR

Harvest Natural

$6.68

0.04 (0.60%)

08:55
02/23/17
02/23
08:55
02/23/17
08:55
Conference/Events
Harvest Natural to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:54
02/23/17
02/23
08:54
02/23/17
08:54
Hot Stocks
Tennant to reduce 3% of global workforce »

Tennant announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:53
02/23/17
02/23
08:53
02/23/17
08:53
Earnings
Tennant sees 2017 adjusted EPS $2.50-$2.70, consensus $2.83 »

On an as adjusted and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

STNG

Scorpio Tankers

$4.28

-0.01 (-0.23%)

08:53
02/23/17
02/23
08:53
02/23/17
08:53
Upgrade
Scorpio Tankers rating change  »

Scorpio Tankers upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

KSS

Kohl's

08:52
02/23/17
02/23
08:52
02/23/17
08:52
Hot Stocks
Kohl's sees significant improvement in Q1 gross margin »

Sees significant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 19

    Mar

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:51
02/23/17
02/23
08:51
02/23/17
08:51
Earnings
Tennant reports Q4 EPS 85c, consensus 76c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

LMRK

Landmark Infrastructure

08:50
02/23/17
02/23
08:50
02/23/17
08:50
Syndicate
Breaking Syndicate news story on Landmark Infrastructure »

Landmark Infrastructure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

KSS

Kohl's

, UA

Under Armour

$19.78

0.09 (0.46%)

08:50
02/23/17
02/23
08:50
02/23/17
08:50
Hot Stocks
Kohl's CEO believes uncertainty in sector will continue »

Kohl's (KSS) says…

KSS

Kohl's

UA

Under Armour

$19.78

0.09 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 19

    Mar

ABBV

AbbVie

$61.36

-0.47 (-0.76%)

, AGN

Allergan

$246.32

-0.84 (-0.34%)

08:50
02/23/17
02/23
08:50
02/23/17
08:50
Conference/Events
Piper Jaffray healthcare/pharma analyst holds analyst/industry conference call »

Analyst Schimmer, along…

ABBV

AbbVie

$61.36

-0.47 (-0.76%)

AGN

Allergan

$246.32

-0.84 (-0.34%)

BMY

Bristol-Myers

$55.35

0.57 (1.04%)

ENTA

Enanta

$28.18

-0.36 (-1.26%)

GALT

Galectin Therapeutics

$1.71

-0.23 (-11.86%)

GILD

Gilead

$68.83

-0.46 (-0.66%)

GLMD

Galmed

$4.09

-0.16 (-3.76%)

ICPT

Intercept

$122.79

-2.66 (-2.12%)

MRK

Merck

$65.29

-0.19 (-0.29%)

RGLS

Regulus

$1.08

-0.025 (-2.27%)

VKTX

Viking Therapeutics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 02

    Mar

  • 06

    Mar

  • 06

    Mar

  • 08

    Mar

  • 09

    Mar

  • 15

    Mar

  • 17

    Mar

  • 01

    Apr

  • 04

    May

  • 10

    May

  • 27

    May

  • 14

    Jun

08:50
02/23/17
02/23
08:50
02/23/17
08:50
General news
Atlanta Fed centrist Lockhart sees the pendulum swinging »

Atlanta Fed centrist…

W

Wayfair

$41.26

1 (2.48%)

08:49
02/23/17
02/23
08:49
02/23/17
08:49
Hot Stocks
Breaking Hot Stocks news story on Wayfair »

Wayfair down 10.3% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

TWX

Time Warner

$96.32

-0.1 (-0.10%)

, T

AT&T

$41.59

-0.14 (-0.34%)

08:46
02/23/17
02/23
08:46
02/23/17
08:46
Periodicals
Time Warner IR head to lead AT&T integration, THR reports »

Time Warner (TWX) head of…

TWX

Time Warner

$96.32

-0.1 (-0.10%)

T

AT&T

$41.59

-0.14 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 06

    Mar

QQQ

NASDAQ 100 Index Tracking Stock

$130.50

0.05 (0.04%)

, ETE

Energy Transfer Equity

$18.92

-0.13 (-0.68%)

08:46
02/23/17
02/23
08:46
02/23/17
08:46
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

QQQ

NASDAQ 100 Index Tracking Stock

$130.50

0.05 (0.04%)

ETE

Energy Transfer Equity

$18.92

-0.13 (-0.68%)

FIT

Fitbit

$5.88

-0.16 (-2.65%)

NAK

Northern Dynasty

$1.39

-0.27 (-16.27%)

BX

Blackstone

$30.32

-0.23 (-0.75%)

PCLN

Priceline

$1,651.74

4.74 (0.29%)

TBT

ProShares UltraShort 20+ yr Trsry

$39.71

-0.14 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Feb

  • 28

    Feb

TNC

Tennant

$70.10

-1.9 (-2.64%)

08:45
02/23/17
02/23
08:45
02/23/17
08:45
Hot Stocks
Tennant announces agreement with Ambienta to acquire IPC Group for $350M »

Tennant Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

08:45
02/23/17
02/23
08:45
02/23/17
08:45
General news
Treasury Action: yields remained downwardly biased »

Treasury Action: yields…

08:45
02/23/17
02/23
08:45
02/23/17
08:45
General news
FHFA House Price Index M/M change to be reported at 09:00 »

December FHFA House Price…

ICON

Iconix Brand

$9.18

-0.03 (-0.33%)

08:43
02/23/17
02/23
08:43
02/23/17
08:43
Recommendations
Iconix Brand analyst commentary  »

Roth Capital remains a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.